0001925468-24-000002.txt : 20240503
0001925468-24-000002.hdr.sgml : 20240503
20240503163159
ACCESSION NUMBER: 0001925468-24-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
EFFECTIVENESS DATE: 20240503
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: QuantBio Innovations Fund LP
CENTRAL INDEX KEY: 0001925468
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-444527
FILM NUMBER: 24913742
BUSINESS ADDRESS:
STREET 1: C/O QUANTBIO MANAGEMENT LLC
STREET 2: 1700 BROADWAY, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-257-5850
MAIL ADDRESS:
STREET 1: C/O QUANTBIO MANAGEMENT LLC
STREET 2: 1700 BROADWAY, 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001925468
QuantBio Innovations Fund LP
C/O QUANTBIO MANAGEMENT LLC
1700 BROADWAY, 24TH FLOOR
NEW YORK
NY
NEW YORK
10019
212-257-5850
DELAWARE
None
None
Limited Partnership
true
2021
JEAN-PIERRE
NAEGELI
C/O QUANTBIO MANAGEMENT LLC
1700 BROADWAY, 24TH FLOOR
NEW YORK
NY
NEW YORK
10019
Executive Officer
ANDREW
RUBINSTEIN
C/O QUANTBIO MANAGEMENT LLC
1700 BROADWAY, 24TH FLOOR
NEW YORK
NY
NEW YORK
10019
Executive Officer
Pooled Investment Fund
Hedge Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
true
0001925468-23-000001
2022-05-09
true
true
false
0
GALLATIN CAPITAL LLC
124738
None
None
444 MADISON AVENUE
29TH FLOOR
NEW YORK
NY
NEW YORK
10022
All States
false
Indefinite
3836000
Indefinite
false
12
0
0
0
false
QuantBio Innovations Fund LP
DAVID DUBINSKY
DAVID DUBINSKY
AUTHORIZED SIGNATORY OF THE GENERAL PARTNER
2024-05-03